Highly Influential Citations2
Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
The choice of a rituximab-based regimen and the prognostic significance of interim 2-[fluorine-18]fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in primary… Continue Reading
Background: Ibrutinib is an orally-administered inhibitor of Bruton9s tyrosine kinase. It is an effective agent in diffuse large B cell lymphoma (DLBCL), specifically of the Activated (ABC) type… Continue Reading